Teva Asks Supreme Court To Hear ‘Skinny Label’ Suit

By John Wilkerson / July 15, 2022 at 4:41 PM

Teva asked the U.S. Supreme Court to hear a case over whether brand drug makers can patent new uses to keep generic competition at bay.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.